Thomas Griffith

Citée par

	Toutes	Depuis 2020
Citations	24058	5737
indice h	70	37
indice i10	165	109

1300

650

325

975

19961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202574 234 334 569 749 856 828 939 825 960 900 941 803 872 838 908 881 834 802 817 768 715 723 950 1069 1283 1062 1123 1075 120

Accès public

Tout afficher

93 articles

5 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Thomas FergusonProfessor, ophthalmlogy and Visual siencesAdresse e-mail validée de wustl.edu
Vladimir BadovinacDepartment of Pathology, Carver College of Medicine, University of Iowa, Iowa City, IAAdresse e-mail validée de uiowa.edu
Salih SanliogluHuman Gene and Cell Therapy Center of Akdeniz University, Antalya, TurkeyAdresse e-mail validée de akdeniz.edu.tr
Thomas BrunnerUniversität KonstanzAdresse e-mail validée de uni-konstanz.de
David M FergusonProfessor of Medicinal Chemistry University of MinnesotaAdresse e-mail validée de umn.edu
Jayanth PanyamUniversity of MinnesotaAdresse e-mail validée de umn.edu
John HartyUniversity of IowaAdresse e-mail validée de uiowa.edu
William M. NauseefProfessor of Medicine, University of IowaAdresse e-mail validée de uiowa.edu
David Masopust PhDUniversity of MinnesotaAdresse e-mail validée de umn.edu
Prajwal GurungAssociate Professor at the University of IowaAdresse e-mail validée de uiowa.edu
Stephen P. SchoenbergerLa Jolla Institute for ImmunologyAdresse e-mail validée de lji.org
LALIT BEURABrown UniversityAdresse e-mail validée de brown.edu
S.C. JamesonUniversity of MinnesotaAdresse e-mail validée de umn.edu
Mary M. KavurmaHeart Research InstituteAdresse e-mail validée de hri.org.au
Badrinath KonetyProfessor, Urology, University of MinnesotaAdresse e-mail validée de umn.edu
Gustavo P. Amarante-MendesDepartamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de São PauloAdresse e-mail validée de usp.br
Daniel L. MuellerUniversity of MinnesotaAdresse e-mail validée de umn.edu
Brian T. FifeUniversity of MinnesotaAdresse e-mail validée de umn.edu
Molly IngersollInstitut PasteurAdresse e-mail validée de pasteur.fr
Jesse Warren WilliamsUniversity of Minnesota Medical SchoolAdresse e-mail validée de umn.edu

Suivre

Thomas Griffith

University of Minnesota

Adresse e-mail validée de umn.edu

immunology sepsis apoptosis inflammation


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo H Walczak, RE Miller, K Ariail, B Gliniak, TS Griffith, M Kubin, W Chin, ... Nature medicine 5 (2), 157-163, 1999	3152	1999
Fas ligand-induced apoptosis as a mechanism of immune privilege TS Griffith, T Brunner, SM Fletcher, DR Green, TA Ferguson Science 270 (5239), 1189-1192, 1995	2752	1995
Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells TS Griffith, WA Chin, GC Jackson, DH Lynch, MZ Kubin The journal of immunology 161 (6), 2833-2840, 1998	902	1998
CD4⁺ T-cell help controls CD8⁺ T-cell memory via TRAIL-mediated activation-induced cell death EM Janssen, NM Droin, EE Lemmens, MJ Pinkoski, SJ Bensinger, ... Nature 434 (7029), 88-93, 2005	842	2005
Intravascular staining for discrimination of vascular and tissue leukocytes KG Anderson, K Mayer-Barber, H Sung, L Beura, BR James, JJ Taylor, ... Nature protocols 9 (1), 209-222, 2014	797	2014
Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade Z Wang, EG Aguilar, JI Luna, C Dunai, LT Khuat, CT Le, A Mirsoian, ... Nature medicine 25 (1), 141-151, 2019	741	2019
Monocyte-mediated tumoricidal activity via the tumor necrosis factor–related cytokine, TRAIL TS Griffith, SR Wiley, MZ Kubin, LM Sedger, CR Maliszewski, NA Fanger The Journal of experimental medicine 189 (8), 1343-1354, 1999	632	1999
TRAIL: a molecule with multiple receptors and control mechanisms TS Griffith, DH Lynch Current opinion in immunology 10 (5), 559-563, 1998	626	1998
Human dendritic cells mediate cellular apoptosis via tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) NA Fanger, CR Maliszewski, K Schooley, TS Griffith The Journal of experimental medicine 190 (8), 1155-1164, 1999	537	1999
CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. PM Stuart, TS Griffith, N Usui, J Pepose, X Yu, TA Ferguson The Journal of clinical investigation 99 (3), 396-402, 1997	484	1997
CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance TS Griffith, X Yu, JM Herndon, DR Green, TA Ferguson Immunity 5 (1), 7-16, 1996	475	1996
Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand M Ehtesham, P Kabos, MAR Gutierrez, NHC Chung, TS Griffith, KL Black, ... Cancer research 62 (24), 7170-7174, 2002	395	2002
The role of FasL-induced apoptosis in immune privilege TS Griffith, TA Ferguson Immunology today 18 (5), 240-244, 1997	351	1997
Functional analysis of TRAIL receptors using monoclonal antibodies TS Griffith, CT Rauch, PJ Smolak, JY Waugh, N Boiani, DH Lynch, ... The Journal of Immunology 162 (5), 2597-2605, 1999	331	1999
Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis Y Gao, JM Herndon, H Zhang, TS Griffith, TA Ferguson The Journal of experimental medicine 188 (5), 887-896, 1998	286	1998
CD8 T cells utilize TRAIL to control influenza virus infection EL Brincks, A Katewa, TA Kucaba, TS Griffith, KL Legge The Journal of Immunology 181 (7), 4918-4925, 2008	282	2008
Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis TS Griffith, RD Anderson, BL Davidson, RD Williams, TL Ratliff The Journal of Immunology 165 (5), 2886-2894, 2000	271	2000
TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies PA Holoch, TS Griffith European journal of pharmacology 625 (1-3), 63-72, 2009	270	2009
Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8+ T cells produce active immune unresponsiveness TA Ferguson, J Herndon, B Elzey, TS Griffith, S Schoenberger, DR Green The Journal of Immunology 168 (11), 5589-5595, 2002	240	2002
Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis A Algeciras-Schimnich, TS Griffith, DH Lynch, CV Paya The Journal of Immunology 162 (9), 5205-5211, 1999	224	1999

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs